Clonal haematopoiesis and risk of chronic liver diseaseWaihay J. Wong, Stella Aslibekyan, Connor A. Emdin et al.|Nature|2023Cited by 200
Molecular MRD is strongly prognostic in patients with <i>NPM1</i>-mutated AML receiving venetoclax-based nonintensive therapyJad Othman, Richard Dillon, Ing Soo Tiong et al.|Blood|2023Cited by 65
Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cellsRob S. Sellar, Benjamin L. Ebert, Adam S. Sperling et al.|Journal of Clinical Investigation|2022Cited by 64
Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic MalignanciesAline Renneville, Benjamin L. Ebert, Andrew A. Guirguis et al.|Blood Cancer Discovery|2021Cited by 46
Outcomes with single-agent gilteritinib for relapsed or refractory <i>FLT3</i>-mutant AML after contemporary induction therapyJad Othman, Richard Dillon, Angela Hwang et al.|Blood Advances|2024Cited by 10